Management of neuronopathic Gaucher disease: A European consensus

Journal of Inherited Metabolic Disease

Volumn 24, Issue 3, 2001, Pages 319-327

  Vellodi, A ^a   Bembi, B ^b   De Villemeur, T B ^c   Collin Histed, T ^d   Erikson, A ^e   Mengel, E ^f   Rolfs, A ^g   Tylki Szymanska, A ^h  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b INSTITUTE FOR MATERNAL AND CHILD HEALTH IRCCS BURLO GAROFOLO   (Italy)

^c ARMAND TROUSSEAU HOSPITAL   (France)

^d Gaucher Association of the United Kingdom   (United Kingdom)

^e UMEÅ UNIVERSITY   (Sweden)

^f JOHANNES GUTENBERG UNIVERSITY   (Germany)

^g UNIVERSITY OF ROSTOCK   (Germany)

^h Child Health Institute   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSYLCERAMIDASE; IMIGLUCERASE;

ARTICLE; BONE MARROW TRANSPLANTATION; BRAIN; CLINICAL EXAMINATION; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DISEASE CLASSIFICATION; DRUG CHOICE; ENZYME REPLACEMENT; FAMILY COUNSELING; GAUCHER DISEASE; HUMAN; NEUROLOGIC EXAMINATION; NEUROPHYSIOLOGY; NEUROPSYCHOLOGICAL TEST; PATIENT COUNSELING; PATIENT MONITORING; SPLENECTOMY; TREATMENT INDICATION;

COUNSELING; EUROPE; FAMILY; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HUMANS; RECOMBINANT PROTEINS;

EID: 0034912891     PISSN: 01418955     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1010514614570     Document Type: Article

References (19)

1. Gaucher's disease variant characterized by progressive calcification of heart valves and unique genotype
2. Gaucher disease
3. Pathological findings in Gaucher disease type 2 patients following enzyme therapy
4. Changes in serum chitotriosidase activity with cessation of replacement therapy (cerebrosidase) administration in Gaucher disease
5. Ethical considerations for enzyme replacement therapy in neuronopathic Gaucher disease
6. Gaucher disease--Norrbottnian type (III). Neuropaediatric and neurobiological aspects of clinical patterns and treatment
7. Enzyme replacement therapy of infantile Gaucher disease
8. Neuronopathic forms of Gaucher's disease Ballière's
9. Ocular motor abnormalities in Gaucher disease
10. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation
11. Rapidly progressive type III Gaucher disease: Deterioration following partial splenectomy
12. Isolated horizontal supranuclear gaze palsy as a marker of severe systemic involvement in Gaucher disease
13. Gaucher disease: Enzyme therapy in the acute neuronopathic variant
14. Ten years' experience of bone marrow transplantation for Gaucher disease
15. Prospective study of neurological responses to treatment with macrophage-targeted glucocerebrosidase in patients with type 3 Gaucher's disease
16. Types I and III Gaucher disease in Poland: Incidence of the most common mutations and phenotypic manifestations
17. New Gaucher disease mutation in exon 10: A novel L444R mutation produces a new NciI site the same as L444P
18. The management of children with neuronopathic Gaucher disease; a single-centre experience
19. Prediction of severity of Gaucher's disease by identification of mutations at DNA level